Antifungal Agents Flashcards
Amphotericin A and B are antifungal antibiotics produced by
Streptomyces nodosus.
Amphotericin B is an?
amphoteric polyene macrolide (polyene =
containing many double bonds; macrolide = containing a large
lactone ring of 12 or more atoms)
Amphotericin B is nearly insoluble in water
and is therefore prepared as a?
colloidal suspension of amphotericin B and sodium desoxycholate for intravenous injection
New formulation of Amphotericin B
packaged in a lipid-associated delivery system
Most expensive lipid formulation of amphotericin B
AmBisome
lipid formulation of amphotericin B with 3 - 5 dosing
AmBisome
Lipid formulation of amphotericin B with highest Cmax
AmBisome
Lipid formulation of Amphotericin B with infusional toxicity
Amphotec
Oral amphotericin B is thus effective only on?
fungi within
the lumen of the tract and cannot be used for treatment of systemic
disease because it is poorly absorbed from the GIT
amphotericin B is excreted slowly in the ____ over a period of several days
urine
Dose adjustment is required in amphotericin B. True or false?
False
How many % of the blood level of amphotericin B is reached in the CSF, necessisating intrathecal therapy for fungal meningitis?
2 - 3%
Amphotericin B is selective in its fungicidal effect because?
It only targets fungal cell membrane, Ergosterol
Amphotericin B binds to ergosterol and alters the permeability of the cell by forming?
amphotericin B-associated pores in the cell membrane
Amphipathic characteristic of Amphotericin B binds with ergosterol along the _____ of its structure and associates with water molecules along the _____
double bond-rich side (around outside the pore)
hydroxyl-rich side (lining the inside)
MOA of amphotericin B
Formation of pores on the cell membrane bilayer, allowing leakage of intracellular ions and molecules
2 mechanisms of resistance/impairing ergosterol binding by amphotericin B
- Decreasing the membrane concentration of ergosterol
2. Modifying the sterol target molecule to reduce its affinity for the drug
Antifungal agent with the broadest spectrum of activity.
Amphotericin B
With intrinsic amphotericin B resistance
Candida lusitaniae and Pseudallescheria boydii
Useful agent for all life-threatening mycotic infections
Amphotericin B
Often used as the initial induction regimen to rapidly reduce fungal burden
amphotericin B
Used for immunosuppressed patients and those with severe fungal pneumonia, severe cryptococcal meningitis or disseminated infections with endemic mycoses such as histoplasmosis or coccidiodomycosis
Amphotericin B
Once initial therapy with amphotericin B is used, what med is used as maintenance therapy?
-azoles
For treatment of systemic fungal disease. amphotericin B is given by?
Slow IV infusion at 0.5 - 1 mg/kg/day
Amphotericin B is continued to a defined total dose rather than a defined time span. True or false?
True
Which remains an option in cases of fungal CNS infections that have not responded to other agents?
Intrathecal amphotericin B though it is poorly tolerated and CSF access is difficult
Mycotic corneal ulcers and keratitis may be cured with what kind of amphotericin B formulations/method of administration?
topical drops and direct subconjuctival injection
Type of amphotericin B toxicty that manifests as fever, chills, muscle spasms, vomiting, headache, and hypotension
Infusion-Related Toxicity
How to treat Infusion-Related Toxicity of amphotericin B?
by slowing the infusion rate or
decreasing the daily dose
Premids for amphotericin B
antipyretics, antihistamines, meperidine, or corticosteroids
When starting amphotericin B , what should be done to gauge the severity of the reaction?
administer a test dose of 1 mg intravenously to serve as a guide to an initial dosing regimen and premedication
strategy
occurs in nearly all patients treated with clinically significant doses of amphotericin
Renal damage
A reversible component of amphotericin B renal damage that is associated with a form of prerenal renal
failure
decreased renal perfusion
results from renal tubular
injury and subsequent dysfunction in amphotericin B toxicity
Irreversible renal damage
The irreversible form of
amphotericin nephrotoxicity usually occurs in the setting of?
prolonged administration (> 4 g cumulative dose)
Renal toxicity in amphotericin B use is commonly manifested as?
renal tubular acidosis and severe potassium
and magnesium wasting
It is common practice to administer daily doses of amphotericin B with _____ to attenuate prerenal component of cumulative toxicity
normal saline infusions
After intrathecal therapy with amphotericin, _____ may develop,
often with serious neurologic sequelae.
seizures and a chemical arachnoiditis
Other occasionally seen AEs of amphotericin B
Abnormalities of liver function tests
Reduced erythropoietin production
by damaged renal tubular cells
MOA of Flucytosine (5-FC)
Inhibition of RNA and DNA synthesis
water-soluble pyrimidine analog related to the
chemotherapeutic agent 5-fluorouracil (5-FU)
Flucytosine (5-FC)
Which has a narrower spectrum of activity, 5-FU or amphotericin B?
5-FU
5-FU is well absorbed (> 90%), with serum
concentrations peaking ___ after oral dose
1–2 hours
5-FU is poorly protein bound. True or false?
True
5-FU can penetrate CSF. True or False?
True
5-FU is eliminated by?
eliminated by glomerular
filtration with a half-life of 3–4 hours and is removed by hemodialysis
5-Fu toxicity is more likely to occur in?
AIDS patients
and those with renal insufficiency
Peak serum concentrations of 5-FU
should be measured periodically in patients with renal insufficiency
and maintained between?
between 50 and 100 mcg/mL
Flucytosine is taken up by fungal cells via the enzyme?
cytosine permease
MOA of flucytosine
It is converted intracellularly first to 5-FU and then to
5-fluorodeoxyuridine monophosphate (FdUMP) and fluorouridine
triphosphate (FUTP), which inhibit DNA and RNA synthesis,
respectively
in 5-FU, human cells are unable to convert the
parent drug to its active metabolites, resulting in selective toxicity. True or false?
True
5-FC is synergistic with which drug?
amphotericin B
Resistance to 5-FU is via?
altered metabolism
of flucytosine develops rapidly in monotherapy
The spectrum of activity of flucytosine is restricted to?
C neoformans, some Candida sp, and the dematiaceous molds that cause
chromoblastomycosis
Clinical use of 5-FC
confined to combination therapy:
+ AmpB = cryptococcal meningitis
+ itraconazole = chromoblastomycosis
The adverse effects of flucytosine result from metabolism
(possibly by intestinal flora) to the toxic antineoplastic compound?
fluorouracil
most common adverse effects of flucytosine
Bone marrow toxicity with anemia, leukopenia, and thrombocytopenia with
derangement of liver enzymes occurring less frequently; toxic enterocolitis can occur
Azoles are synthetic compounds that can be classified as either
imidazoles or triazoles according to the number of?
nitrogen atoms in the five-membered azole ring
Azoles now used only in topical therapy?
miconazole, and clotrimazole
The triazoles include?
itraconazole, fluconazole, voriconazole, and posaconazol
The antifungal activity of azole drugs results from?
the reduction of
ergosterol synthesis by inhibition of fungal cytochrome P450
enzymes
Which has a lesser degree of selectivity accounting for their higher incidence of drug
interactions and adverse effects?
Imidazoles vs triazoles
azole drugs with high water solubility
Fluconazole
Voriconazole